News tagged with antibodies
Low levels of lipid antibodies increase complications following heart attack
Coronary patients with low levels of an immune system antibody called anti-PC, which neutralises parts of the "bad" cholesterol, run a greater risk of suffering complications following an acute cardiac episode and thus of ...
Medicine & Health / Cardiology
Feb 06, 2012 |
not rated yet |
0
Rituximab possible treatment option for patients with primary biliary cirrhosis
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, ...
Feb 02, 2012 |
not rated yet |
0
Seasonal changes may influence the efficacy of vaccination against diabetes
The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects. One possible explanation ...
Feb 01, 2012 |
5 / 5 (1) |
0
2012 adult immunization schedule broadens recommendations for HPV and hepatitis B vaccinations
The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the ...
Feb 01, 2012 |
5 / 5 (1) |
0
Does Borna disease virus cause mental illness? New study may end two decades of suspicion
Over the past 30 years, numerous studies have linked Borna disease virus (BDV) with mental illnesses such as bipolar disorder, schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies to this RNA virus, ...
Medicine & Health / Psychology & Psychiatry
Jan 31, 2012 |
5 / 5 (1) |
0
|
PFCs, chemicals in environment, linked to lowered immune response to childhood vaccinations
A new study finds that perfluorinated compounds (PFCs), widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging, were associated with lowered immune response to vaccinations ...
Jan 24, 2012 |
4 / 5 (1) |
0
|
Study identifies a cause of resistance to colon cancer treatment
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal ...
Jan 22, 2012 |
5 / 5 (1) |
0
A new way to stimulate the immune system and fight infection
A study carried out by Eric Vivier and Sophie Ugolini at the Marseille-Luminy Centre for Immunology has just reveal a gene in mice which, when mutated, can stimulate the immune system to help fight against tumors and viral ...
Jan 20, 2012 |
5 / 5 (3) |
0
New silicon probe assists in disease diagnostics and drug discovery
IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon can aid researchers and pathologists to investigate critical tissue samples accurately for disease diagnostics and ...
Jan 13, 2012 |
2 / 5 (1) |
0
|
Discovery in Africa gives insight for Australian Hendra virus outbreaks
A new study on African bats provides a vital clue for unravelling the mysteries in Australia's battle with the deadly Hendra virus.
Jan 12, 2012 |
not rated yet |
0
Experimental vaccine partially protects monkeys from HIV-like infection
Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys. In addition, in the animals that became infected, ...
Medicine & Health / HIV & AIDS
Jan 04, 2012 |
not rated yet |
0
|
Another potential obstacle to developing an HIV vaccine
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work.
Medicine & Health / HIV & AIDS
Dec 27, 2011 |
2 / 5 (2) |
0
Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke.
Dec 27, 2011 |
not rated yet |
0
The existence of neutrophils in the spleen discovered
For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital ...
Dec 25, 2011 |
4.6 / 5 (5) |
1
|
Cell membrane proteins could provide targets for broader vaccines
Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh ...
Dec 22, 2011 |
4.7 / 5 (3) |
0
|
Antibody
Antibodies (also known as immunoglobulins, abbreviated Ig) are gamma globulin proteins that are found in blood or other bodily fluids of vertebrates, and are used by the immune system to identify and neutralize foreign objects, such as bacteria and viruses. They are typically made of basic structural units—each with two large heavy chains and two small light chains—to form, for example, monomers with one unit, dimers with two units or pentamers with five units. Antibodies are produced by a kind of white blood cell called a plasma cell. There are several different types of antibody heavy chains, and several different kinds of antibodies, which are grouped into different isotypes based on which heavy chain they possess. Five different antibody isotypes are known in mammals, which perform different roles, and help direct the appropriate immune response for each different type of foreign object they encounter.
Although the general structure of all antibodies is very similar, a small region at the tip of the protein is extremely variable, allowing millions of antibodies with slightly different tip structures, or antigen binding sites, to exist. This region is known as the hypervariable region. Each of these variants can bind to a different target, known as an antigen. This huge diversity of antibodies allows the immune system to recognize an equally wide diversity of antigens. The unique part of the antigen recognized by an antibody is called an epitope. These epitopes bind with their antibody in a highly specific interaction, called induced fit, that allows antibodies to identify and bind only their unique antigen in the midst of the millions of different molecules that make up an organism. Recognition of an antigen by an antibody tags it for attack by other parts of the immune system. Antibodies can also neutralize targets directly by, for example, binding to a part of a pathogen that it needs to cause an infection.
The large and diverse population of antibodies is generated by random combinations of a set of gene segments that encode different antigen binding sites (or paratopes), followed by random mutations in this area of the antibody gene, which create further diversity. Antibody genes also re-organize in a process called class switching that changes the base of the heavy chain to another, creating a different isotype of the antibody that retains the antigen specific variable region. This allows a single antibody to be used by several different parts of the immune system. Production of antibodies is the main function of the humoral immune system.
For more information about Antibody, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.